Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Characterization of an Onchocerca volvulus L3-specific larval antigen, Ov-ALT-1.

× No keyword cloud information.

19 in total

Review 1. A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors: C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal: Clin Microbiol Rev Date: 2013-07 Impact factor: 26.132

2. Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography.

Authors: Surianarayanan Bhuvanesh; Chakkaravarthi Arunkumar; Perumal Kaliraj; Subramanian Ramalingam
Journal: J Ind Microbiol Biotechnol Date: 2010-07-01 Impact factor: 3.346

3. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.

Authors: W F Gregory; A K Atmadja; J E Allen; R M Maizels
Journal: Infect Immun Date: 2000-07 Impact factor: 3.441

4. Molecular characterization and evaluation of Onchocerca volvulus-secreted larval acidic protein 1 (SLAP1) as a putative vaccine candidate on endemic population of lymphatic filariasis.

Authors: Natarajan Mahalakshmi; Ramanathan Aparnaa; Lawrance Ansel Vishal; Perumal Kaliraj
Journal: Parasitol Res Date: 2013-07-05 Impact factor: 2.289

5. Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.

Authors: D Abraham; O Leon; S Leon; S Lustigman
Journal: Infect Immun Date: 2001-01 Impact factor: 3.441

6. Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries.

Authors: M Lizotte-Waniewski; W Tawe; D B Guiliano; W Lu; J Liu; S A Williams; S Lustigman
Journal: Infect Immun Date: 2000-06 Impact factor: 3.441

7. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.

Authors: P S Turaga; T J Tierney; K E Bennett; M C McCarthy; S C Simonek; P A Enyong; D W Moukatte; S Lustigman
Journal: Infect Immun Date: 2000-04 Impact factor: 3.441

8. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.

Authors: Angus J MacDonald; Prasad S D Turaga; Carolyn Harmon-Brown; Tracy J Tierney; Kristine E Bennett; Maggie C McCarthy; Scott C Simonek; Peter A Enyong; Daniel W Moukatte; Sara Lustigman
Journal: Infect Immun Date: 2002-06 Impact factor: 3.441

9. Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi.

Authors: Munirathinam Gnanasekar; Kakaturu V N Rao; Yi-Xun He; Pankaj K Mishra; Thomas B Nutman; Perumal Kaliraj; Kalyanasundaram Ramaswamy
Journal: Infect Immun Date: 2004-08 Impact factor: 3.441

10. Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure.

Authors: Benjamin L Makepeace; Siv Aina Jensen; Sandra J Laney; Charles K Nfon; Leo M Njongmeta; Vincent N Tanya; Steven A Williams; Albert E Bianco; Alexander J Trees
Journal: PLoS Negl Trop Dis Date: 2009-11-10